Start Date
May 31, 2004
edifoligide (E2F Decoy)
NYU Medical Center, New York
St. Luke's Hospital, Department of Surgery, New York
Montefiore Medical Center, The Bronx
University of Rochester, The Center for Vascular Disease, Rochester
Nephrology Clinical Research Center, Charlottesville
Surgical Education, Greenville
Emory University, Renal Division, Atlanta
University of Miami, School of Medicine, Miami
Tampa General Hospital, Tampa
LifeLink Transplant Institute, Tampa
Outcomes Research International, Inc., Hudson
Methodist Hospital, Tower Surgical, Indianapolis
Henry Ford Hospital, Detroit
Thoracic & Cardiovascular Healthcare Foundation, Lansing
University Transplant, Chicago
Stoney Island Dialysis, Chicago
St. Louis University, Division of Nephrology, St Louis
Tulane Center for Abdominal Transplant, New Orleans
Vascular Surgery Associates, Baton Rouge
University of Utah School of Medicine, Dept of Surgery, Salt Lake City
National Institute of Clinical Research, American Medical Tower, Los Angeles
Lead Sponsor
Anesiva, Inc.
INDUSTRY